Security key
64134X201
Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS)
CUSIP: 64134X201
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 11,508,976
- Total 13F shares
- 110,906
- Share change
- +36,317
- Total reported value
- $308,337
- Price per share
- $2.78
- Number of holders
- 10
- Value change
- +$100,958
- Number of buys
- 7
- Number of sells
- 1
Report period
Q2 2024
Institutions
10
Top holders
10
NRXS full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Neuraxis, INC SEC filings
Neuraxis, INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 64134X201
Recent filing periods:
Top shareholders of NRXS - Neuraxis, INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Christopher Robin Brown |
3/4/5
|
DIRECTOR OF INNOVATION, Director |
—
class O/S missing
|
792,837
|
$2,069,305 | — | 08 Aug 2023 | |
| Gary Merril Peterson |
3/4/5
|
DIR.OF DESIGN & ENGINEERING |
—
class O/S missing
|
518,120
|
$1,352,293 | — | 08 Aug 2023 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.22%
|
25,710
|
$80,215 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.15%
|
17,745
|
$55,364 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.13%
|
15,101
|
$47,000 | — | 31 Mar 2024 | |
| PARSONS CAPITAL MANAGEMENT INC/RI |
13F
|
Company |
0.11%
|
13,000
|
$40,560 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
2,805
|
$8,752 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
215
|
$671 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
7
|
$22 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
6
|
$19 | — | 31 Mar 2024 |
Institutional Holders of Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS) as of Q2 2024
As of 30 Jun 2024,
Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
110,906 shares.
The largest 10 holders included
VANGUARD GROUP INC, STIFEL FINANCIAL CORP, Royal Bank of Canada, CITADEL ADVISORS LLC, PARSONS CAPITAL MANAGEMENT INC/RI, GEODE CAPITAL MANAGEMENT, LLC, Tower Research Capital LLC (TRC), UBS Group AG, BANK OF AMERICA CORP /DE/, and JPMORGAN CHASE & CO.
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
8
Q2 2024 holders
10
Holder diff
2
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.